Human Health Holdings Management

Management criteria checks 3/4

Human Health Holdings' CEO is Kin Ping Chan, appointed in Jun 2015, has a tenure of 9.42 years. total yearly compensation is HK$4.36M, comprised of 57.5% salary and 42.5% bonuses, including company stock and options. directly owns 1.8% of the company’s shares, worth HK$5.41M. The average tenure of the management team and the board of directors is 9.3 years and 9.4 years respectively.

Key information

Kin Ping Chan

Chief executive officer

HK$4.4m

Total compensation

CEO salary percentage	57.5%
CEO tenure	9.4yrs
CEO ownership	1.8%
Management average tenure	9.3yrs
Board average tenure	9.4yrs

Recent management updates

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

CEO Compensation Analysis

How has Kin Ping Chan's remuneration changed compared to Human Health Holdings's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	HK$4m	HK$3m	HK$24m
Mar 31 2024	n/a	n/a	-HK$22m
Dec 31 2023	n/a	n/a	-HK$67m
Sep 30 2023	n/a	n/a	HK$57m
Jun 30 2023	HK$5m	HK$2m	HK$181m
Mar 31 2023	n/a	n/a	HK$367m
Dec 31 2022	n/a	n/a	HK$553m
Sep 30 2022	n/a	n/a	HK$464m
Jun 30 2022	HK$3m	HK$2m	HK$375m
Mar 31 2022	n/a	n/a	HK$297m
Dec 31 2021	n/a	n/a	HK$218m
Sep 30 2021	n/a	n/a	HK$181m
Jun 30 2021	HK$2m	HK$2m	HK$144m
Mar 31 2021	n/a	n/a	HK$59m
Dec 31 2020	n/a	n/a	-HK$27m
Sep 30 2020	n/a	n/a	-HK$33m
Jun 30 2020	HK$2m	HK$2m	-HK$40m
Mar 31 2020	n/a	n/a	-HK$11m
Dec 31 2019	n/a	n/a	HK$19m
Sep 30 2019	n/a	n/a	HK$23m
Jun 30 2019	HK$2m	HK$2m	HK$27m
Mar 31 2019	n/a	n/a	HK$26m
Dec 31 2018	n/a	n/a	HK$25m
Sep 30 2018	n/a	n/a	HK$24m
Jun 30 2018	HK$2m	HK$2m	HK$24m

Compensation vs Market: Kin Ping's total compensation ($USD559.65K) is above average for companies of similar size in the Hong Kong market ($USD233.03K).

Compensation vs Earnings: Kin Ping's compensation has been consistent with company performance over the past year.

CEO

Kin Ping Chan (60 yo)

9.4yrs

Tenure

HK$4,358,000

Compensation

Mr. Kin Ping Chan, BBS, J.P, serves as the Chairman of the Board at Human Health Holdings Limited and has been its Chief Executive Officer and Executive Director since June 9, 2015. Mr. Chan is a Co-Owner...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Kin Ping Chan	Chairman of the Board & CEO	9.4yrs	HK$4.36m	1.8% HK$ 5.4m
Chun Pong Poon	COO & Executive Director	11.2yrs	HK$3.96m	0.13% HK$ 384.0k
Lai Sheung Pang	Chief Medical Officer & Executive Director	no data	HK$4.36m	no data
Tin Wai Chan	Group CFO	1.8yrs	no data	no data
Siu Keung Seto	Co-Head of Dental Unit	9.3yrs	no data	no data
Wai Man Lau	Co-Head of Dental Unit	9.3yrs	no data	no data
Ching Yan Man	Company Secretary	7.4yrs	no data	no data

9.3yrs

Average Tenure

58yo

Average Age

Experienced Management: 1419's management team is seasoned and experienced (9.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Kin Ping Chan	Chairman of the Board & CEO	9.4yrs	HK$4.36m	1.8% HK$ 5.4m
Chun Pong Poon	COO & Executive Director	9.4yrs	HK$3.96m	0.13% HK$ 384.0k
Lai Sheung Pang	Chief Medical Officer & Executive Director	9.4yrs	HK$4.36m	no data
Yue Kwong Chan	Independent Non-Executive Director	8.8yrs	HK$180.00k	no data
Sun Wing Lui	Independent Non-Executive Director	8.8yrs	HK$180.00k	no data
Kar Tim Sin	Independent Non-Executive Director	8.8yrs	HK$180.00k	no data
Kin Hung Kwong	Member of Doctor Advisory Board	15.3yrs	no data	no data
Huen Lee	Member of Doctor Advisory Board	12.1yrs	no data	no data
Hey Man Chan	Independent Non-Executive Director	less than a year	no data	no data

9.4yrs

Average Tenure

57yo

Average Age

Experienced Board: 1419's board of directors are considered experienced (9.4 years average tenure).

Human Health Holdings Management

Management criteria checks 3/4

Key information

Recent management updates

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Less than half of directors are independent

Recent updates

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age